Secretory phospholipase A2-mediated progression of hepatotoxicity initiated by acetaminophen is exacerbated in the absence of hepatic COX-2. | Toxicol Appl Pharmacol;251(3): 173-80, 2011 Mar 15. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Secretory phospholipase A2-mediated progression of hepatotoxicity initiated by acetaminophen is exacerbated in the absence of hepatic COX-2.

Bhave, Vishakha S; Donthamsetty, Shashikiran; Latendresse, John R; Cunningham, Michael L; Mehendale, Harihara M.

Affiliation

Bhave VS; Department of Toxicology, College of Pharmacy, University of Louisiana at Monroe, Monroe, LA 71209-0470, USA.

Toxicol Appl Pharmacol ; 251(3): 173-80, 2011 Mar 15.

Article in En | MEDLINE | ID: mdl-21277885

Subject(s)

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Analgesics, Non-Narcotic / Cyclooxygenase 2 / Phospholipases A2, Secretory / Chemical and Drug Induced Liver Injury / Acetaminophen Limits: Animals Language: En Journal: Toxicol Appl Pharmacol Year: 2011 Document type: Article Affiliation country:

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Analgesics, Non-Narcotic / Cyclooxygenase 2 / Phospholipases A2, Secretory / Chemical and Drug Induced Liver Injury / Acetaminophen Limits: Animals Language: En Journal: Toxicol Appl Pharmacol Year: 2011 Document type: Article Affiliation country: